Mechanisms of Kidney Stone Formation and Management

Kidney stone formation arises from a cascade of physicochemical and biological events within the urinary tract. Supersaturation of urine with calcium, oxalate, urate or phosphate initiates nucleation of microscopic crystal seeds. These seeds grow and aggregate, often adhering to renal epithelium and becoming retained in the renal papillae. Randall’s plaques—subepithelial calcified deposits—provide attachment sites for calcium oxalate crystals, facilitating stone nidus formation. Local tissue injury, oxidative stress and immune activation further alter extracellular matrix remodelling and cellular adhesion dynamics, promoting crystal retention and stone growth. Endogenous inhibitors such as citrate, magnesium and macromolecular proteins counterbalance promoters including low urine volume, acidic pH and elevated urinary concentrations of lithogenic ions. Management strategies combine preventive and interventional approaches: high fluid intake, dietary modification (reduced sodium, balanced calcium and oxalate), urinary alkalinisation and pharmacotherapy (citrate supplements, thiazide diuretics) aim to reduce supersaturation and inhibit crystal growth. Established calculi are addressed by minimally invasive endourological techniques or shockwave lithotripsy. Emerging research focuses on metabolic profiling, novel crystal growth modifiers and targeted molecular therapies to disrupt early nucleation and aggregation steps, moving towards personalised risk assessment and non-invasive dissolution strategies.

Research from Nature Portfolio

Recent studies have applied spatially anchored transcriptomic analysis to the human renal papilla, revealing a widespread injury signature in stone formers characterised by immune activation, oxidative stress and remodelling of the extracellular matrix. Increased expression of specific metalloproteinases correlated with both tissue mineral deposition and urinary biomarker levels, linking papillary injury pathways directly to stone pathogenesis. In mechanistic work on citrate, early-stage interactions have been identified between citrate ions and polynuclear calcium-oxalate complexes, demonstrating that citrate stabilises transient amorphous precursors and inhibits nucleation prior to crystal formation. This non-classical view of citrate action refines our understanding of inhibitor dynamics and suggests novel timing targets for therapeutic intervention in biomineralisation processes.

Mechanisms of Kidney Stone Formation and Management publication trend

The graph below shows the total number of articles in mechanisms of kidney stone formation and management across all publications each year (not limited to Nature Index journals).

Technical terms

Supersaturation: Condition in which urinary solute concentration exceeds its solubility, driving crystal formation.

Nucleation: Initial aggregation of solute molecules into a stable cluster that seeds crystal growth.

Randall’s plaque: Subepithelial calcium phosphate deposit on the renal papilla that acts as a nidus for stone attachment.

Transcriptomic atlas: Spatially resolved mapping of gene expression across tissue regions, identifying cell types and molecular pathways.

Metabolomics: Comprehensive profiling of small-molecule metabolites in biological fluids to discover biomarkers and therapeutic targets.

References

1. Application of metabolomics in urolithiasis: the discovery and usage of succinate. Signal Transduction and Targeted Therapy (2023).
2. A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nature Communications (2023).
3. Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization. Advanced Science (2024).
4. Kidney Stone Disease: An Update on Current Concepts. Advances in Urology (2018).
5. A non-classical view on calcium oxalate precipitation and the role of citrate. Nature Communications (2017).